Simcere Pharmaceutical Group Limited Stock
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Delayed
Hong Kong S.E.
06:21:39 15/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.91 HKD | +0.28% |
|
-0.73% | -8.94% |
| 10-13 | Major drugmakers turn to China for licensing deals | RE |
| 10-02 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 3.56B 27.94B 3.2B 2.99B 2.71B 5.08B 339B 5.11B 35.85B 14B 176B 13.37B 13.08B 566B | P/E 2026 * |
13.5x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.36B 26.39B 3.02B 2.82B 2.56B 4.8B 320B 4.83B 33.86B 13.22B 166B 12.63B 12.35B 534B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 1.95x |
| Free-Float |
33.7% | Yield 2026 * |
3.88% | Yield 2027 * | 4.41% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHGF | Delayed | |
|
Boerse Muenchen
| S2P | Real-time | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed |
| 1 day | +0.18% | ||
| 1 week | -0.73% | ||
| Current month | -8.02% | ||
| 1 month | -3.11% | ||
| 3 months | -16.09% | ||
| 6 months | -21.98% | ||
| Current year | -8.94% |
| 1 week | 10.5 |  | 11.1 |
| 1 month | 10.5 | | 11.89 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 A | Other | Chairperson | -3,000,000 | 0.1168% | ||
| 7/13/26 A | Other | Founder | -47,000 | 0.0018% | ||
| 7/13/26 A | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.28% | -0.73% | -11.09% | +66.41% | 3.51B | |
| +3.62% | +1.68% | +48.80% | +98.41% | 1,040B | |
| +2.13% | -1.76% | +33.04% | +61.88% | 599B | |
| +3.32% | +4.47% | +23.72% | +91.59% | 485B | |
| +3.80% | +3.21% | +73.99% | +41.69% | 350B | |
| +3.09% | +3.03% | +29.59% | +45.42% | 345B | |
| +2.82% | +2.20% | +17.90% | +40.15% | 272B | |
| +3.40% | +0.99% | -3.44% | +12.08% | 244B | |
| +3.21% | +3.15% | +45.01% | +49.99% | 223B | |
| +3.80% | +4.56% | +29.59% | +97.73% | 183B | |
| Average | +2.73% | +1.01% | +28.71% | +60.54% | 374.63B | |
| Weighted average by Cap. | +2.66% | +1.52% | +36.74% | +68.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.51B 11.85B 1.36B 1.27B 1.15B 2.15B 144B 2.17B 15.2B 5.93B 74.55B 5.67B 5.54B 240B | 1.76B 13.79B 1.58B 1.47B 1.34B 2.51B 167B 2.52B 17.69B 6.91B 86.78B 6.6B 6.45B 279B |
| Net income | 257M 2.01B 231M 215M 195M 366M 24.43B 369M 2.58B 1.01B 12.68B 964M 943M 40.78B | 303M 2.38B 273M 255M 231M 433M 28.88B 436M 3.06B 1.19B 14.99B 1.14B 1.11B 48.21B |
| Net Debt | -197M -1.55B -177M -166M -150M -282M -18.78B -283M -1.99B -776M -9.75B -741M -725M -31.34B | -140M -1.1B -126M -117M -106M -200M -13.3B -201M -1.41B -549M -6.9B -525M -513M -22.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | HK$10.91 | +0.28% | 1,081,000 |
| 14/10/26 | HK$10.88 | +1.49% | 2,487,000 |
| 13/10/26 | HK$10.72 | -1.65% | 5,233,215 |
| 12/10/26 | HK$10.90 | +0.09% | 1,771,000 |
| 09/10/26 | HK$10.89 | -0.82% | 4,810,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
